Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000283888 | SCV000339512 | benign | not specified | 2016-02-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000283888 | SCV000524330 | benign | not specified | 2016-09-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001514268 | SCV001722068 | benign | Adams-Oliver syndrome 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001514268 | SCV002026861 | benign | Adams-Oliver syndrome 5 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000616716 | SCV002026862 | benign | Aortic valve disease 1 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000283888 | SCV003928457 | benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000616716 | SCV000734682 | likely benign | Aortic valve disease 1 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000283888 | SCV001809595 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000283888 | SCV001924333 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000283888 | SCV001956399 | benign | not specified | no assertion criteria provided | clinical testing |